The combined effects of hepatic and extrahepatic mediators on activating STING lead to enhanced macrophage proinflammatory activation, which in turn promotes liver inflammation and causes dysregulation of hepatocyte fat metabolism to trigger or exacerbate hepatic steatosis. The gene discussed is STING1; the disease is fatty liver disease.